Page last updated: 2024-09-04

conivaptan and Hyponatremia

conivaptan has been researched along with Hyponatremia in 93 studies

Research

Studies (93)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (1.08)18.2507
2000's49 (52.69)29.6817
2010's43 (46.24)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenberg, A; Lehrich, RW; Ortiz-Melo, DI; Patel, MB1
Aghi, MK; Blevins, L; Jahangiri, A; Kunwar, S; Miller, LM; Tom, MW; Tran, MT; Wagner, J1
Blevins, LS; Breshears, JD; Jiang, B; Kunwar, S; Rowland, NC1
Buckley, MS; Culver, MA; Hattrup, AE; Jacobs, SC; Kazem, NH; Patel, SA1
Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K1
Iwao, H; Izumi, Y; Miura, K1
Adams, KF; Lin, TE; Patterson, JH1
Tanındı, A; Töre, HF1
Palmer, BF; Rock, AD; Woodward, EJ1
Bhandari, S; Cranston, I; Glanville, J; McCool, R; O'Reilly, K; Peri, A; Petrakova, L; Shaw, A1
Berger, K; Der-Nigoghossian, C; Lesch, C1
Laczi, F1
Chini, B; Durroux, T; Guillon, G; Manning, M; Mouillac, B; Stoev, S1
Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT1
Kumar, SK; Mather, PJ1
Keating, GM; Moen, MD1
Asbury, WH; Gilmore, JL; Samuels, OB; Wright, WL1
Annane, D; Decaux, G; Smith, N1
Dhar, R; Diringer, M; Murphy, T1
Arai, Y; Fujimori, A; Miyata, K; Sasamata, M1
Elhassan, E; Masoumi, A; Schrier, RW1
Krahn, TA; Mount, DB1
Afiniwala, M; Arumugham, P; Hoque, MZ; Huda, N; Karia, DH; Verma, N1
Keirns, J; Mao, ZL; Stalker, D1
Davis, GL; O'Leary, JG1
Haass, M1
Arthur, JM; Delay, TA; Dopson, SJ; Sanders, DS; Velez, JC1
Gross, P1
Keegan, MT; Wright, DR1
Reilly, T; Schork, MR1
Bar-Or, D; Garrett, RE; Maerz, G; Wilhelm, S1
Dhar, R; Murphy-Human, T1
Ghali, JK; Tam, SW1
Carluccio, AL; Merlin, MA; Zenenberg, RD1
Hopkins, JP; Oliphant, CS; Pinner, NA1
Alberts, MJ; Bassin, SL; Bernstein, RA; Leibling, SM; Levasseur, K; Liebling, SM; Muro, K; Naidech, AM; Paparello, J1
Blevins, LS; McDermott, M; Sughrue, ME1
Komai, Y; Palaniyandi, SS; Sukumaran, V; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K1
Singh, M; Slawsky, MT; Valania, G1
Chiong, JR; Jao, GT1
Cantillo, DS; Comín Colet, J; Robledo, GG1
Villabona, C1
Hix, J; Sterns, R1
Abeyratne, A; Arthur, JM; Efrati, S; Kalra, S; Klasen, S; McNutt, BE; Oliven, A; Velez, JC1
Decaux, G; Gross, PA; Wagner, A1
Abeyratne, A; Hamad, A; Kalra, S; Klasen, S; Koren, MJ; McNutt, BE1
Bianzina, S; Dal Canton, A; Esposito, P; Malul, Y; Piotti, G1
Blevins, LS; DeGiacomo, AF; Deragopian, L; Potts, MB1
Cassagnol, M; Saad, M; Shogbon, AO1
Fujiwara, Y; Koshimizu, TA; Tanoue, A; Tsujimoto, G1
Caimi, G; Urso, C1
Alemayehu, A; O'Connell, JB1
Dhar, R; Diringer, M; Human, T; Onuoha, A1
Dabrowska, MD; Krysiak, R; Okopień, B1
Cirulli, J; Friedman, B1
Balaguru, D; Bricker, JT; Haque, I; Pham-Peyton, C; Sahu, R; Thapar, V1
Marik, PE; Rivera, R1
Peri, A1
Doggrell, SA1
Brooks-Asplund, E; Fan, K; Ghali, JK; Koren, MJ; Long, WA; Smith, N; Taylor, JR1
Pham, PC; Pham, PM; Pham, PT1
Greenberg, A; Verbalis, JG1
Gross, P; Quittnat, F1
O'Connor, CM; Starling, RC; Wagoner, LE1
Gross, P; Herbrig, K; Palm, C; Pistrosch, F1
Verbalis, JG1
Ginès, P; Guevara, M; Martín-Llahí, M1
Hays, RM1
Arai, Y; Fujimori, A; Matsukawa, U; Miyata, K; Sasamata, M; Sudoh, K; Wada, K1
Oh, MS1
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P1
Balk, RA; Patel, GP1
Berl, T; Ellison, DH1
Walter, KA1
Rosansky, S; Smith, N; van Rensburg, H; Verbalis, JG; Zeltser, D1
Lien, YH; Shapiro, JI1
Kumar, S; Mather, PJ; Rubin, S; Whellan, DJ1
Ali, F; Ghali, JK; Raufi, MA; Washington, B1
Haskal, R1
Głuszek, J; Olszewski, W1
Andoh, M; Barve, A; Smith, N; Verbalis, JG; Zeltser, D1
Cárdenas, A; Ginès, P1
Siegel, AJ1
DeVita, MV; Metzger, BL; Michelis, MF1
Schweiger, TA; Zdanowicz, MM1
Cain, JP; Rianthavorn, P; Turman, MA1
Decaux, G; Soupart, A; Vassart, G1
Honda, K; Iizumi, Y; Kusayama, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Wada, K; Yatsu, T1
Bichet, DG; Davids, MR; Edoute, Y; Halperin, ML; Mallie, JP1
Martinez-Castelao, A1

Reviews

55 review(s) available for conivaptan and Hyponatremia

ArticleYear
Role of vaptans in the management of hyponatremia.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013, Volume: 62, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Humans; Hyponatremia; Male; Middle Aged; Pyrroles; Tolvaptan

2013
Conivaptan for treatment of hyponatremia in neurologic and neurosurgical adults.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:9

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Neurosurgical Procedures

2013
Management of hyponatremia.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, May-13, Volume: 186, Issue:8

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome

2014
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
    Journal of pharmacological sciences, 2014, Volume: 124, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling

2014
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
    Heart failure clinics, 2014, Volume: 10, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Prospective Studies; Tolvaptan; Vasopressins

2014
[Use of "Vaptans" in treatment of hyponatremia].
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2015, Volume: 43, Issue:3

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Contraindications; Humans; Hyponatremia; Tolvaptan

2015
A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans.
    Clinical endocrinology, 2017, Volume: 86, Issue:6

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Osmotic Pressure; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Spiro Compounds; Tolvaptan

2017
[Etiology, diagnostics and therapy of hyponatremias].
    Orvosi hetilap, 2008, Jul-20, Volume: 149, Issue:29

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins

2008
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Progress in brain research, 2008, Volume: 170

    Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Lypressin; Oligopeptides; Oxytocin; Peptides; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Structure-Activity Relationship; Terlipressin; Uterus; Vasodilator Agents; Vasopressins

2008
Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
    Current heart failure reports, 2008, Volume: 5, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Assessment; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance

2008
AVP receptor antagonists in patients with CHF.
    Heart failure reviews, 2009, Volume: 14, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Sodium

2009
New topics in vasopressin receptors and approach to novel drugs: research and development of conivaptan hydrochloride (YM087), a drug for the treatment of hyponatremia.
    Journal of pharmacological sciences, 2009, Volume: 109, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Humans; Hyponatremia; Research Design

2009
Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome.
    Blood purification, 2009, Volume: 27, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hyponatremia; Kidney; Kidney Diseases; Vasopressins

2009
[Vasopressin receptor antagonists and heart failure].
    Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:11

    Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan

2009
Tolvaptan (Samsca) for hyponatremia.
    The Medical letter on drugs and therapeutics, 2009, Nov-30, Volume: 51, Issue:1326

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Approval; Drug Interactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Tolvaptan; United States; United States Food and Drug Administration

2009
Sodium, potassium and glucose management in organ transplantation.
    Current opinion in organ transplantation, 2010, Volume: 15, Issue:3

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Glucose; Fluid Therapy; Humans; Hyperglycemia; Hyperkalemia; Hypoglycemia; Hypoglycemic Agents; Hyponatremia; Organ Transplantation; Perioperative Care; Potassium; Sodium; Transplantation, Homologous; Treatment Outcome

2010
Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
    The Annals of pharmacotherapy, 2010, Volume: 44, Issue:4

    Topics: Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Neurotransmitter Agents; Pyrroles; Tolvaptan; Vasopressins

2010
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.
    Journal of cardiac failure, 2010, Volume: 16, Issue:5

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Blood Pressure; Blood Volume; Female; Heart Failure; Humans; Hypertension; Hyponatremia; Male; Prevalence; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; United States; Water-Electrolyte Balance

2010
Hyponatremia: evaluation and management.
    Hospital practice (1995), 2010, Volume: 38, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; Cardiac Output, Low; Causality; Diagnosis, Differential; Glomerular Filtration Rate; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules; Saline Solution, Hypertonic; Sodium; Tolvaptan; Uric Acid; Water-Electrolyte Balance

2010
Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents.
    Drug discovery today, 2010, Volume: 15, Issue:19-20

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Drug Evaluation, Preclinical; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan

2010
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
    Current heart failure reports, 2011, Volume: 8, Issue:3

    Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins

2011
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.
    Clinical cardiology, 2010, Volume: 33, Issue:11

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Fluid Therapy; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Receptors, Vasopressin; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Ventricular Dysfunction

2010
[Hyponatremia in heart failure: physiopathology and pharmacological approach].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Brain Edema; Demyelinating Diseases; Diuresis; Diuretics; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Kidney; Multicenter Studies as Topic; Natriuresis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Renin-Angiotensin System; Saline Solution, Hypertonic; Sympathetic Nervous System; Tolvaptan

2010
[Vasopressin receptor antagonists: the vaptans].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins

2010
Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
    Kidney international, 2011, Volume: 80, Issue:6

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Costs; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan

2011
The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options.
    Nephron. Clinical practice, 2011, Volume: 119, Issue:1

    Topics: Animals; Benzazepines; Disease Management; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neurophysins; Protein Precursors; Vasopressins; Water-Electrolyte Balance

2011
The therapeutic use of vaptans for the treatment of dilutional hyponatremia.
    Journal of pharmacy practice, 2011, Volume: 24, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Interactions; Humans; Hyponatremia; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance

2011
The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.
    Clinical and experimental nephrology, 2012, Volume: 16, Issue:1

    Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Blood Volume; Heart Failure; Homeostasis; Humans; Hyponatremia; Mice; Receptors, Vasopressin; Renin-Angiotensin System

2012
[Hyponatremic syndrome].
    La Clinica terapeutica, 2012, Volume: 163, Issue:1

    Topics: Aging; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Brain Edema; Exercise; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infections; Inflammation; Kidney; Natriuresis; Neoplasms; Osmotic Pressure; Renal Replacement Therapy; Sodium; Tolvaptan; Water Intoxication

2012
Hyponatremia, heart failure, and the role of tolvaptan.
    Postgraduate medicine, 2012, Volume: 124, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Heart Failure; Humans; Hyponatremia; Prognosis; Tolvaptan; Treatment Outcome

2012
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan

2012
Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan.
    Journal of critical care, 2013, Volume: 28, Issue:2

    Topics: Age Factors; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Temperature; Creatinine; Critical Care; Health Status Indicators; Humans; Hyponatremia; Intensive Care Units; Prevalence; Tolvaptan; Water-Electrolyte Imbalance

2013
Clinical review: the use of vaptans in clinical endocrinology.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Discovery; Endocrinology; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Models, Biological; Tolvaptan

2013
Vasopressin excess and hyponatremia.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:5

    Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance

2006
Vasopressin receptor antagonists.
    Kidney international, 2006, Volume: 69, Issue:12

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins

2006
Vaptans and the treatment of water-retaining disorders.
    Seminars in nephrology, 2006, Volume: 26, Issue:3

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan; Vasopressins; Water

2006
Cardiac function and heart failure.
    Journal of the American College of Cardiology, 2006, Jun-06, Volume: 47, Issue:11 Suppl

    Topics: Adrenergic beta-Antagonists; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Carbazoles; Cardiac Output, Low; Carvedilol; Child; Diuretics; Genomics; Heart; Hemofiltration; Humans; Hyponatremia; Propanolamines

2006
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    The American journal of medicine, 2006, Volume: 119, Issue:7 Suppl 1

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins

2006
AVP receptor antagonists as aquaretics: review and assessment of clinical data.
    Cleveland Clinic journal of medicine, 2006, Volume: 73 Suppl 3

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance

2006
Hyponatremia in cirrhosis: clinical features and management.
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:10

    Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Brain; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Creatinine; Forecasting; Hepatic Encephalopathy; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Prognosis; Research; Risk Factors; Sodium; Time Factors; Treatment Outcome

2006
Management of hyponatremia and clinical use of vasopressin antagonists.
    The American journal of the medical sciences, 2007, Volume: 333, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia

2007
Therapeutic potential of vasopressin receptor antagonists.
    Drugs, 2007, Volume: 67, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan

2007
Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
    Clinical therapeutics, 2007, Volume: 29, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Critical Illness; Humans; Hyponatremia; Inpatients; Practice Guidelines as Topic; Pyrroles; Randomized Controlled Trials as Topic; Tolvaptan

2007
Clinical practice. The syndrome of inappropriate antidiuresis.
    The New England journal of medicine, 2007, May-17, Volume: 356, Issue:20

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Carcinoma, Small Cell; Dysgeusia; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Osmolar Concentration; Saline Solution, Hypertonic; Urine

2007
Conivaptan: new treatment for hyponatremia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Jul-01, Volume: 64, Issue:13

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Costs; Drug Interactions; Heart Failure; Humans; Hyponatremia

2007
Hyponatremia: clinical diagnosis and management.
    The American journal of medicine, 2007, Volume: 120, Issue:8

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Kidney Concentrating Ability; Kidney Tubules, Collecting; Male; Osmolar Concentration; Vasopressins

2007
Hyponatremia and vasopressin antagonism in congestive heart failure.
    Clinical cardiology, 2007, Volume: 30, Issue:11

    Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Models, Biological; Pyrroles; Registries; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Vasopressins

2007
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
    Cardiovascular drug reviews, 2007,Fall, Volume: 25, Issue:3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Molecular Structure; Platelet Aggregation; Treatment Outcome

2007
Current issues for nurse practitioners: Hyponatremia.
    Journal of the American Academy of Nurse Practitioners, 2007, Volume: 19, Issue:11

    Topics: Aged; Algorithms; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Causality; Decision Trees; Diagnosis, Differential; Early Diagnosis; Female; Homeostasis; Humans; Hyponatremia; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Selection; Primary Health Care; Pyrroles; Tolvaptan; Water-Electrolyte Balance

2007
[Vasopressin antagonists in treatment of hyponatremia].
    Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:8

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance

2007
The management of ascites and hyponatremia in cirrhosis.
    Seminars in liver disease, 2008, Volume: 28, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diet, Sodium-Restricted; Diuretics; Humans; Hyponatremia; Liver Cirrhosis; Prognosis

2008
Hyponatremia in psychiatric patients: update on evaluation and management.
    Harvard review of psychiatry, 2008, Volume: 16, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drinking Behavior; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mental Disorders; Psychotropic Drugs; Risk Factors; Water-Electrolyte Balance

2008
Vasopressin-receptor antagonists in heart failure.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, May-01, Volume: 65, Issue:9

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan

2008
Non-peptide arginine-vasopressin antagonists: the vaptans.
    Lancet (London, England), 2008, May-10, Volume: 371, Issue:9624

    Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Contraindications; Humans; Hyponatremia; Models, Molecular; Receptors, Vasopressin

2008
Conivaptan (Yamanouchi).
    Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:1

    Topics: Animals; Benzazepines; Clinical Trials as Topic; Edema; Heart Failure; Humans; Hyponatremia; Technology, Pharmaceutical

2002

Trials

8 trial(s) available for conivaptan and Hyponatremia

ArticleYear
Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia--efficacy, safety, and pharmacokinetics.
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Blood Volume; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Male; Middle Aged; Treatment Outcome; Young Adult

2016
Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia.
    The American journal of the medical sciences, 2009, Volume: 337, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Humans; Hyponatremia; Male; Middle Aged; Sodium

2009
Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients.
    Neurocritical care, 2010, Volume: 13, Issue:1

    Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glasgow Coma Scale; Humans; Hyponatremia; Injections, Intravenous; Intensive Care Units; Male; Middle Aged; Pilot Projects; Prospective Studies; Severity of Illness Index; Single-Blind Method; Sodium; Time Factors; Young Adult

2010
Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Apr-01, Volume: 68, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Blood Volume; Chemistry, Pharmaceutical; Female; Follow-Up Studies; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult

2011
Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, May-01, Volume: 68, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Water; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyponatremia; Infusions, Intravenous; Least-Squares Analysis; Male; Middle Aged; Sodium; Time Factors; Young Adult

2011
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:6

    Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Female; Humans; Hyponatremia; Male; Sodium

2006
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
    American journal of nephrology, 2007, Volume: 27, Issue:5

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyponatremia; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Single-Blind Method; Sodium; Time Factors; Treatment Outcome

2007
Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study.
    Clinical endocrinology, 2008, Volume: 69, Issue:1

    Topics: Aged; Aged, 80 and over; Benzazepines; Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hormone Antagonists; Humans; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Placebos; Sodium; Treatment Outcome

2008

Other Studies

30 other study(ies) available for conivaptan and Hyponatremia

ArticleYear
Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.
    Journal of neurosurgery, 2013, Volume: 119, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Child, Preschool; Female; Humans; Hyponatremia; Hypopituitarism; Inappropriate ADH Syndrome; Male; Middle Aged; Neurosurgical Procedures; Pituitary Gland; Postoperative Complications; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome; Young Adult

2013
Use of conivaptan for management of hyponatremia following surgery for Cushing's disease.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:11

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cushing Syndrome; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Sodium; Water Deprivation

2013
Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
    Pharmacotherapy, 2017, Volume: 37, Issue:5

    Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cohort Studies; Critical Illness; Female; Humans; Hypokalemia; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome

2017
Intravenous conivaptan.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2008, Volume: 8, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Hyponatremia; Infusions, Intravenous

2008
Conivaptan for hyponatremia in the neurocritical care unit.
    Neurocritical care, 2009, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Critical Care; Drug Monitoring; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Receptors, Vasopressin; Retrospective Studies; Sodium; Young Adult

2009
Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.
    Neurocritical care, 2009, Volume: 11, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Critical Care; Dose-Response Relationship, Drug; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pulse Therapy, Drug; Retrospective Studies; Sodium; Specific Gravity; Urine

2009
Hyponatremia: case vignettes.
    Seminars in nephrology, 2009, Volume: 29, Issue:3

    Topics: Adult; Aged; Benzazepines; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Male; Middle Aged; Saline Solution, Hypertonic; Tolvaptan; Treatment Outcome

2009
Conivaptan: promise of treatment in heart failure.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:13

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin

2009
Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
    Clinical therapeutics, 2009, Volume: 31, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Half-Life; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Young Adult

2009
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2009, Volume: 15, Issue:10

    Topics: Adult; Aged; Benzazepines; Drug Administration Schedule; Female; Humans; Hyponatremia; Liver Failure; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk; Sodium; Time Factors; Treatment Outcome

2009
Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Urea Nitrogen; Female; Glomerular Filtration Rate; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Male; Middle Aged; Sodium

2010
The vaptans: just landed. But how was the trip?
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:5

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome

2010
Vasopressin receptor antagonist use in a neurologic rehabilitation center.
    The journal of spinal cord medicine, 2010, Volume: 33, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Male; Middle Aged; Quadriplegia; Substance Abuse Treatment Centers

2010
A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury.
    Neurocritical care, 2011, Volume: 14, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Injuries; Cerebral Angiography; Female; Humans; Hyponatremia; Intracranial Hypertension; Tomography, X-Ray Computed; Young Adult

2011
Use of conivaptan for the treatment of symptomatic hyponatremia in a patient with acute decompensated heart failure.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Jun-15, Volume: 67, Issue:12

    Topics: Aged; Benzazepines; Blood Urea Nitrogen; Cardiac Catheterization; Creatinine; Defibrillators, Implantable; Female; Heart Failure; Humans; Hyponatremia; Injections, Intravenous; Receptors, Vasopressin

2010
Extreme correction of hyponatremia in a patient treated with intravenous conivaptan.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:10

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Neoplasms; Female; Fourth Ventricle; Humans; Hyponatremia; Injections, Intravenous; Intracranial Aneurysm; Magnetic Resonance Imaging; Sodium; Tomography Scanners, X-Ray Computed; Young Adult

2010
Hyponatremia: vasopressin antagonists in hyponatremia: more data needed.
    Nature reviews. Nephrology, 2011, Volume: 7, Issue:3

    Topics: Benzazepines; Clinical Trials as Topic; Drug Resistance; Humans; Hyponatremia; Tolvaptan; Vasopressins

2011
Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.
    Neurosurgery, 2011, Volume: 69, Issue:2

    Topics: Adult; Aged; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Middle Aged; Retrospective Studies

2011
Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury.
    Journal of critical care, 2012, Volume: 27, Issue:6

    Topics: Administration, Intravenous; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Injuries; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Sodium

2012
Conivaptan therapy in an infant with severe hyponatremia and congestive heart failure.
    Texas Heart Institute journal, 2012, Volume: 39, Issue:5

    Topics: Benzazepines; Female; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Infant; Neurophysins; Protein Precursors; Severity of Illness Index; Treatment Outcome; Vasopressins

2012
Therapeutic effect of conivaptan bolus dosing in hyponatremic neurosurgical patients.
    Pharmacotherapy, 2013, Volume: 33, Issue:1

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Neurosurgical Procedures; Retrospective Studies; Treatment Outcome

2013
Conivaptan Yamanouchi.
    Current opinion in investigational drugs (London, England : 2000), 2005, Volume: 6, Issue:3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Diuretics; Edema; Heart Failure; Humans; Hyponatremia; Molecular Structure; Structure-Activity Relationship; Vasopressins

2005
Conivaptan (Vaprisol) for hyponatremia.
    The Medical letter on drugs and therapeutics, 2006, Jun-19, Volume: 48, Issue:1237

    Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Administration Schedule; Drug Costs; Drug Interactions; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Kidney Tubules, Collecting; Randomized Controlled Trials as Topic

2006
Vasopressin antagonists--progress and promise.
    The New England journal of medicine, 2006, Nov-16, Volume: 355, Issue:20

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan

2006
A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Osmolar Concentration; Potassium; Rats; Rats, Wistar; Sodium; Water; Water-Electrolyte Balance

2007
Molecule of the Month: Conivaptan hydrochloride.
    Drug news & perspectives, 2006, Volume: 19, Issue:9

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Humans; Hyponatremia

2006
Observations regarding the use of the aquaretic agent conivaptan for treatment of hyponatremia.
    International urology and nephrology, 2008, Volume: 40, Issue:3

    Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome

2008
Use of conivaptan to allow aggressive hydration to prevent tumor lysis syndrome in a pediatric patient with large-cell lymphoma and SIADH.
    Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:8

    Topics: Adolescent; Benzazepines; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lymphoma, Large B-Cell, Diffuse; Male; Severity of Illness Index; Tumor Lysis Syndrome

2008
[Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 114 Suppl 1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Calcium; Cyclic AMP; Dogs; Female; Heart Failure; Humans; Hyponatremia; In Vitro Techniques; Male; Radioligand Assay; Rats; Vasopressins

1999
Body compartment volumes and composition after giving a vasopressin antagonist: changes are revealed by a tonicity balance.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:2

    Topics: Benzazepines; Body Fluid Compartments; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Potassium; Receptors, Vasopressin; Sodium

2002